In Silico Approaches in Benzimidazole Derivatives Research: Recent Insights

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Benzimidazole is a key scaffold in drug discovery with diverse therapeutic applications, including antimicrobial, anticancer, antitubercular, and antiviral activities.
• Recent advancements (2020-2025) leverage computational approaches to expedite benzimidazole drug development and optimize lead compounds.

Purpose of the Study:

• To highlight recent computational insights and best practices in benzimidazole drug discovery.
• To emphasize the integration of various computational workflows for rational drug design.

Main Methods:

• Molecular docking and dynamics simulations to understand scaffold-protein interactions (e.g., π-π stacking, hydrogen bonding, hydrophobic interactions).
• Quantitative Structure-Activity Relationship (QSAR) studies, pharmacophore modeling, and in silico Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictions.
• Integration of Artificial Intelligence (AI) and Machine Learning (ML) with methods like free energy perturbation for enhanced predictive accuracy.

Main Results:

• Computational methods elucidate how modifications at C2, C5, and C6 positions influence binding affinity and selectivity for targets like InhA, DprE1, kinases, and viral proteases.
• Combined computational strategies improve early-stage hit identification and reduce experimental failure rates.
• AI/ML and free energy perturbation enable more accurate predictions and facilitate multi-target drug design.

Conclusions:

• Computational methodologies, including docking, molecular dynamics, QSAR, ADMET, and AI/ML, provide a powerful and cost-effective pipeline for designing novel benzimidazole derivatives.
• These integrated approaches accelerate the development of next-generation benzimidazole-based therapeutics with enhanced efficacy and translational potential.